Treatment options for traumatic abducens nerve injury: a dual-center clinical experience | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Treatment options for traumatic abducens nerve injury: a dual-center clinical experience Xiaofei Hou, Guancheng Hu, Hua Fu, ShengWei Yang This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4625149/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Objective: This study aimed to assess the therapeutic efficacy of surgical and conservative treatments in patients with traumatic abducens nerve injury on neurofunctional recovery based on dual-center clinical experience. Methods: A retrospective analysis was conducted on the clinical data of 71 patients with traumatic abducens nerve injury. Patients were categorized into the operation group and the conservative treatment group based on whether patients underwent surgical intervention during their hospitalization. A comparison was made between the two groups regarding ocular motility recovery before and after treatment. In addition, patients were further divided into complete paralysis and incomplete paralysis groups based on their initial ocular position score for subgroup analysis. Results: The overall effective rate of conservative treatment group was 81.82%, while the overall effective rate of operation group was 88.89%. there is no statistically significant difference (χ 2 =0.173, P=0.678) between two groups. Subgroup analysis indicated that both in the conservative treatment group and in the surgical group, the efficacy rate is significantly lower in the complete paralysis subgroup compared to the incomplete paralysis subgroup. Results showed the total effective rate was 92.31% vs .66.67%(χ 2 =4.70, P<0.05) on conservative treatment group and 100% vs .66.67% (χ 2 =3.857, P<0.05)on operation group. Conclusion: The total effectiveness rate of the conservative treatment group was similar to that of the operation group, suggesting no difference in treatment effectiveness between two treatment plans, and the prognosis of traumatic abducens nerve injuries remains favorable. However, the higher the initial ocular position score of the patient, the more severe the paralysis symptoms, and the worse the treatment effect. Thus, treatment choices should be individualized to ensure optimal results. Health sciences/Diseases/Trauma Health sciences/Neurology/Neurological disorders/Brain injuries traumatic abducens nerve injury ocular position score surgery corticosteroid pulse therapy Introduction The abducens nerve, which is the sixth cranial nerve, innervates the lateral rectus muscle of both eyes, controlling the outward movement of the eyeballs [1] . Over 10% of abducens nerve palsies result from trauma, with approximately 1–2.7% of patients with cranial nerve damage following head trauma experiencing involvement of the abducens nerve [2–3] . The abducens nerve enters the orbit via the superior orbital fissure and has a relatively long course along the skull base, making it particularly susceptible to injury during cranial trauma. Additionally, due to its proximity to the internal carotid artery within the cavernous sinus, increased intracranial pressure following head trauma can also affect the abducens nerve [4] . Following abducens nerve injury, mild symptoms may include limited outward gaze and diplopia, while severe cases can lead to complete inability to abduct the eye, esotropia, compensatory head posture, dizziness, and unsteady gait, significantly impacting the patient's quality of life [5–6] . There is currently no unified standard for the treatment of the traumatic abductor nerve injury [7] . In the early stages, drugs functioned as nourishing nerves, lowering blood pressure, and dilating blood vessels are often chosen for treatment, but the expected therapeutic effects are often not achieved. In some cases, while imaging suggests compression of the abducens nerve by bone fragment, a small surrounding hematoma, or if there is persistent elevation of intracranial pressure, early consideration should be given to performing abducens nerve decompression surgery [8] . However, many questions remain unanswered in clinical practice, such as the efficacy of surgery, indications for surgery, and the optimal timing of surgical intervention. Additionally, some emerging treatments, such as stem cell therapy and neurotrophic factor therapy, are showing promising results [9–10] . Due to the prolonged self-repair period following abducens nerve injury, neurological dysfunction often persists. For neurosurgeons, having clear and effective treatment strategies for abducens nerve injury and reducing treatment duration is of paramount importance. Based on this, we conducted a retrospective analysis of 71 patients with traumatic abducens nerve injury who underwent treatment at the Department of Neurosurgery in the Zhangjiajie People’s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province from January 2021 to December 2023, comparing the efficacy of surgical and conservative treatments, aiming to determine the optimal treatment approach. Methods Participants We collected clinical data from 71 patients diagnosed with traumatic abducens nerve injury who received treatment at the Department of Neurosurgery in both Zhangjiajie People’s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province between January 2021 and December 2023. The inclusion criteria were as follows: (1) binocular diplopia; (2) a clear history of head trauma; (3) diagnosed with unilateral abducens nerve palsy; (4) undergone treatment for at least two weeks; (5) clear consciousness and stable vital signs; (6) age over 18 years. Exclusion criteria are as follows: (1) muscle disorders caused by thyroid dysfunction, myasthenia gravis, or other diseases; (2) congenital strabismus; (3) concurrent paralysis of the trochlear nerve or oculomotor nerve; (4) coma or inability to cooperate. For all included cases, we documented the initial ocular position score, gender, age, injured side, cause of injury, treatment plan, treatment duration, and recovery status of eye movement. All methods were conducted in accordance with relevant guidelines and approved by the Ethics Committees of the Zhangjiajie People’s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province. Diagnosis The diagnosis of traumatic abducens nerve injury was based on the patient's history of trauma, symptoms, and imaging examination results [11] . The diagnosis of the condition is based on the inability of the affected eye to perform outward gaze or limited outward gaze function, with the affected eye deviating towards the nose. Additionally, the patient presents with diplopia and may exhibit compensatory head posture. Grouping All 71 patients included in the study met the clinical diagnostic criteria for traumatic abducens nerve injury, with a history of head and facial trauma. Patients who underwent surgical treatment were categorized into the operation group, while those who did not undergo surgical treatment but instead received steroid pulse therapy supplemented with supportive treatment were classified into the conservative treatment group. All patients’ initial ocular position scores will be recorded and used for subgroup analysis. The ocular position score is determined using the eye movement grading method in the Ocular Motor Nerve Palsy Scale to assess the degree of abduction impairment in patients during their visit [12] . A higher score indicates more severe impairment. Complete paralysis is defined as an ocular movement score of 3 or 4 points, where the center point of the pupil does not reach the midpoint between the inner and outer canthi when attempting maximal abduction. Management For patients in the conservative treatment group, high-dose corticosteroid pulse therapy was typically employed. Initially, within 3–8 hours post-injury, 500mg of methylprednisolone was administered, followed by a 3-day continuous pulse therapy with the dosage adjusted to 300mg, then further adjusted to 100mg after 3 days. Meanwhile, they were supplemented with diuretics, neurotrophic agents, vasodilators, and hyperbaric oxygen therapy. For patients in the operation group, surgical interventions were performed to decompress the abducens nerve. Surgical procedures include both intracranial and extracranial decompression of the abducens nerve, as well as endoscopic trans-nasal decompression. The objective of these surgeries is to alleviate compression on the abducens nerve and facilitate recovery of its function. Following surgery, patients receive antimicrobial therapy, dehydration treatment, vascular nutritional support, and other supportive measures. Measurements Based on reference [13] , the efficacy assessment criteria are formulated as follows: Cured: After treatment, the affected eye exhibits unrestricted outward movement, with no strabismus or diplopia when looking straight ahead, and there is no visual field defect. Marked effective: After treatment, the affected eye exhibits essentially unrestricted outward movement, with no strabismus when looking straight ahead, and the angle of diplopia is less than 30°, and the visual field is basically normal. Effective: After treatment, there is slight improvement in the outward movement of the affected eye, and there are varying degrees of improvement in the strabismus and diplopia when looking straight ahead, with an increase in the visual field compared to before treatment. Ineffective: After treatment, there is no significant change in the outward movement of the affected eye, and there is no change in diplopia, strabismus, or visual field defect. The overall effective rate is calculated as follows: (Number of cured cases + Number of significantly improved cases + Number of effective cases) / Total number of cases × 100%. Statistical analysis Statistical analysis was conducted using SPSS version 26 (IBM Corp., Armonk, NY, USA). Continuous variables are expressed as mean ± standard deviation (X ± S). The t-test was utilized to compare the mean values of continuous variables between two groups. Categorical variables are presented as percentages (%) and were compared between groups using the chi-square test to determine treatment efficacy. A p-value less than 0.05 was considered statistically significant. Results Baseline characteristics of patients This study collected a total of 71 cases of traumatic abducens nerve palsy, including 46 males and 25 females. Among them, 38 cases involved the left eye and 33 cases involved the right eye. Imaging examinations such as head CT and MRI suggested intracranial hemorrhage in 31 cases and orbital fractures in 22 cases. Upon initial presentation, the eye position score was 4 points in 19 cases, 3 points in 17 cases, 2 points in 27 cases, 1 point in 8 cases. Complete paralysis was observed in 36 cases while incomplete paralysis in 35 cases. The onset age ranged from 20 to 66 years, with a mean age of 38.95 ± 13.09 years in conservative treatment group and 38.15 ± 9.82 years in operation group. The results in Table 1 indicate that there were no statistically significant differences (P > 0.05) in gender, age, laterality of eye involvement, or initial ocular position score between two groups, suggesting comparable baseline characteristics between two groups. Table 1 Baseline characteristics of patients Patients Sex(male/female) Age(x^-±s) Side (left/right) ocular position score (complete/ incomplete paralysis) Conservative treatment group 44 28/16 38.95 ± 13.09 25/19 18/26 Operation group 27 18/9 38.15 ± 9.82 13/14 18/9 χ 2 /t - 0.067 0.276 0.506 3.471 P valve - 0.795 0.784 0.477 0.062 Comparison of therapeutic effects between conservative treatment group and operation group The overall effective rate of conservative treatment group was 81.82%, with 9 patients cured, 15 patients showed marked effective, 12 patients showed effective and 8 patients showed ineffective. The overall effective rate of operation group was 88.89%, with 7 patients cured, 9 patients showed marked effective, 5 patients showed effective and 6 patients showed ineffective. No statistically significant difference (χ 2 = 0.173, P = 0.678, Table 2 ) between two groups. Table 2 Comparison of therapeutic effects between conservative treatment group and operation group Patients Cure(%) Marked effective(%) Effective(%) Ineffective(%) Total effective rate(%) Conservative treatment group 44 9(20.45%) 15(34.09%) 12(27.27%) 8(18.18%) 81.82% Operation group 27 7(29.63%) 9(25.93%) 5(33.33%) 6(11.11%) 88.89% χ 2 = 0.173, P = 0.678 Subgroup analysis: Comparison of ocular position score on therapeutic effects Among the patients received conservative treatment, 18 patients’ initial ocular position score were no less than 3 and were diagnosed as complete paralysis, with 26 patients’ initial ocular position score were less than 3 and were diagnosed as incomplete paralysis. The overall effective rate of the incomplete paralysis group was higher than that of the complete paralysis group, with a statistically significant difference (χ 2 = 4.70, P < 0.05, Table 3 ). Among the patients received operation, 18 patients were diagnosed as complete paralysis and 9 patients were diagnosed as incomplete paralysis. There was still statistically significant difference in the overall effective rate between two groups (χ 2 = 3.875, P < 0.05, Table 4 ). Table 3 Comparison of ocular position score on conservative treatment group Patients Cure(%) Marked effective(%) Effective(%) Ineffective(%) Total effective rate(%) Complete paralysis group 18 3(16.67%) 4(22.22%) 5(27.78%) 6(33.33%) 66.67% Incomplete paralysis group 26 6(23.08%) 11(42.31%) 7(26.92%) 2(7.7%) 92.31% χ 2 = 4.70, P < 0.05 Table 4 Comparison of ocular position score on operation group Patients Cure(%) Marked effective(%) Effective(%) Ineffective(%) Total effective rate(%) Complete paralysis group 18 4(22.22%) 5(27.78%) 3(16.67%) 6(33.33%) 66.67% Incomplete paralysis group 9 3(33.33%) 4(44.44%) 2(22.22%) 0(0%) 100% χ 2 = 3.857, P < 0.05 Discussion The abducens nerve originates from the cerebral cortex, descends to the brainstem nuclei, and then emits secondary neuronal fibers to innervate the lateral rectus muscle of the eye [14–15] . Lesions affecting the horizontal gaze center in the pons, as well as lesions in the cerebral cortex and cortical gaze center, can result in paralysis of the extraocular muscles [16] . Due to its relatively long intracranial course, traumatic injury leading to abducens nerve damage is the most common type of peripheral ocular muscle paralysis. After exiting the skull, the abducens nerve traverses the surface of the petrous part of the temporal bone, running between the dura mater and the petrous bone, and then makes a right-angled bend to enter the cavernous sinus [17–18] . This segment of its course is relatively fixed at both ends with little room for movement, making it prone to injury. The abducens nerve must exit the skull through the skull base foramen, which makes it susceptible to injury if the skull base is traumatized and affects the foramen, leading to abducens nerve damage. Skull fractures themselves can cause traction and contusion injuries to intracranial nerves or disrupt the blood supply to cranial nerves due to fracture-related issues, thereby resulting in impairment of the abducens nerve [19–20] . Abducens nerve palsy can be classified according to its etiology into ischemic, compressive, traumatic, and non-specific inflammatory types. Ischemic abducens nerve palsy is often associated with conditions such as diabetes mellitus, hypertension, hyperlipidemia, and a history of cerebrovascular accidents [21–22] . Compressive abducens nerve palsy resulting from intracranial space-occupying lesions typically involves lesions near the abducens nerve nucleus or in close proximity to its fibers [23] . Traumatic abducens nerve palsy is the most common type encountered by neurosurgeons and is often associated with a clear history of trauma. Among our group of cases, car accidents accounted for 32 cases (45.07%), fights for 20 cases (28.17%), falls for 12 cases (16.90%), and other causes for 7 cases (9.9%). Damage to the abducens nerve results in weakness of the innervated lateral rectus muscle, leading to exotropia or diplopia, and severe cases may present with compensatory head posture. Unilateral abducens nerve palsy is more common than bilateral cases and presents with either complete or partial paralysis [24] . Symptoms include esotropia of the affected eye, restricted or absent outward eye movements, compensatory head tilting toward the affected side, and fixation of the gaze toward the unaffected side. Diplopia is pronounced. In severe cases, walking may require occlusion of one eye [25] . Currently, there is still controversy surrounding the treatment approach for traumatic abducens nerve injuries [26–27] . Some physicians advocate for early surgical intervention, especially for patients with bone fragments or small hematomas compressing the abducens nerve, suggesting early decompression surgery. However, other physicians believe that most cases of abducens nerve palsy can recover gradually without surgery, and instead, conservative treatment options such as steroid therapy and neurotrophic drugs can be pursued [28] . Steroids have been validated for their significant role in treating nerve injuries. Corticosteroids, such as prednisone or methylprednisolone, are often used in the management of traumatic abducens nerve injury. In acute nerve injuries, there is often inflammation and swelling around the injured abducens nerve, which can exacerbate tissue damage and impede nerve recovery. Corticosteroids help to reduce this inflammation, potentially minimizing tissue damage and promoting a more favorable environment for nerve regeneration [29] . In addition to their anti-inflammatory effects, corticosteroids may also help prevent secondary damage to nerves. After an initial injury, there can be a cascade of biochemical events that lead to further damage to nerve tissue. Corticosteroids may help to interrupt or mitigate this cascade, limiting the extent of secondary damage [30] . Corticosteroids are typically administered intravenously in acute nerve injury cases. The dosage and duration of treatment may vary depending on the severity of the injury, individual patient factors, and the neurosurgeon's clinical judgment. A typical regimen might involve an initial high dose followed by a tapering course to gradually reduce the dose over time. For patients with evident bone fragments and hematomas compressing the abducens nerve, surgical treatment can be considered. Preoperative assessment through imaging studies and electrophysiology helps identify the site of nerve injury [31] . Surgery can be performed via intracranial or extracranial approaches, where bone fragments compressing the nerve are removed using drilling techniques, hematomas around the nerve are evacuated, and the outer membrane of the nerve is incised under a microscope to achieve decompression. Endoscopic trans-nasal decompression surgery for the abducens nerve has also been utilized. Some institutions have started performing microvascular decompression for the abducens nerve [32] . Currently, there are no randomized controlled studies evaluating the efficacy of different surgical techniques, so the primary criterion for selection remains the proficiency of the clinical surgeon [33] . Our research findings also indicate that there is no significant difference in efficacy between the operation group and the conservative treatment group. The effectiveness rate in the surgical group was 88.89%, while it was 81.82% in the conservative treatment group (χ 2 = 0.173, P = 0.678). Overall, the prognosis of traumatic abducens nerve injuries remains favorable. Based on our clinical experience, for patients with evident bone fragments and hematomas compressing the abducens nerve, surgical treatment should be preferred to relieve the compressed abducens nerve and salvage its function as early as possible. However, for cases where there is no apparent compression of the abducens nerve, the efficacy of surgery may be less significant. Furthermore, some studies have indicated that the combined effect of nerve decompression surgery and steroid treatment is more beneficial. Besides, our research has found that patients with higher ocular position scores tend to have more severe symptoms of abducens nerve palsy, and consequently, poorer treatment outcomes. Patients with a ocular deviation score of 3 or above at the time of diagnosis usually have a worse prognosis. This score represents the extent of outward deviation impairment in patients, with higher scores indicating greater ocular misalignment and more severe conditions, leading to poorer treatment outcomes. Subgroup analysis results demonstrate that both in the conservative treatment group and the surgical group, the efficacy rate is significantly lower in the complete paralysis subgroup (ocular deviation score of 3–4) compared to the incomplete paralysis subgroup (ocular deviation score below 3). Results showed the total effective rate was 92.31% vs .66.67%(χ 2 = 4.70, P < 0.05) on conservative treatment group and 100% vs .66.67% ༈χ 2 = 3.857, P < 0.05༉on operation group. This may be due to an increase in energy production by surviving neurons, with a reduction in acidic metabolic by-products, which in turn self-corrects the imbalance of ions both inside and outside the cells. This process accelerates the regeneration of capillaries and the establishment of collateral circulation, providing damaged nerve tissue with ample nutritional substances, thereby promoting the repair of its own nerve fibers and myelin sheaths. Furthermore, compared to complete paralysis, incomplete paralysis of the abducens nerve still partially innervates the lateral rectus muscle and retains some degree of activity. This helps prevent tissue atrophy and facilitates early restoration of its activity, thereby promoting nerve function recovery. In addition, for patients with strabismus symptoms that are refractory to conservative treatment or decompression surgery, consideration could be given to referring the patient to ophthalmology for corrective surgery after 6–8 months [34–35] . The aim is to achieve visual recovery and promote normal ocular alignment. Traditional corrective surgeries in clinical practice have gradually been phased out with the development of scientific technology due to risks such as anatomical layer disruption and misalignment of incisions, leading to poor treatment outcomes and a higher likelihood of postoperative complications. However, in recent years, the emergence of minimally invasive surgeries has addressed the shortcomings of traditional surgeries [36] . Commonly used procedures include Jensen's procedure, Hummelsheim's procedure, and Brooks' procedure. Microscopic medial rectus transposition surgery is a safe and effective procedure for treating patients with exotropic strabismus caused by complete paralysis of the abducens nerve. Conclusion The total effectiveness rate of the conservative treatment group was similar to that of the operation group, suggesting no difference in treatment effectiveness between two treatment plans, and the prognosis of traumatic abducens nerve injuries remains favorable. However, the higher the initial ocular position score of the patient, the more severe the paralysis symptoms, and the worse the treatment effect. Thus, treatment choices should be individualized to ensure optimal results. Declarations Acknowledgements We are grateful to the participating patients. Author disclosure statement No conflict of interest. Data availability The datasets used and analysed during the current study available from the corresponding author on reasonable request. Ethical Approval The study was approved by the Ethics Committees of the Zhangjiajie People’s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province. Informed written consent for study participation was obtained from all patients. Competing interests No competing financial interests exist. References Alkhatib RF, Chen RC, Sing BWH, Sanamandra SK. Unilateral abducens nerve avulsion injury following trauma. Singapore Med J. 2023 Nov 9. doi: 10.4103/singaporemedj.SMJ-2022-222. Epub ahead of print. PMID: 38037779. Fawaz R, Hedjoudje M, Law-Ye B. Abducens nerve avulsion sustained by traumatic brain injury: A lesion not to be underestimated. J Neurosci Rural Pract. 2023 Oct-Dec;14(4):591-592. doi: 10.25259/JNRP_226_2023. Epub 2023 Jul 5. PMID: 38059240; PMCID: PMC10696310. Heo H, Lambert SR. Ocular Motor Nerve Palsy After Traumatic Brain Injury: A Claims Database Study. J Neuroophthalmol. 2023 Mar 1;43(1):131-136. doi: 10.1097/WNO.0000000000001635. Epub 2022 Jun 14. PMID: 36166785; PMCID: PMC10635738. Sharma A, Nguyen HS, Sharma A, Lozen A, Kurpad S. Delayed hydrocephalus associated with traumatic atlanto-occipital dislocation: Case report and literature review. Surg Neurol Int. 2016 Sep 22;7(Suppl 25):S679-S681. doi: 10.4103/2152-7806.191076. PMID: 27843685; PMCID: PMC5054641. Lee JY, Yoo YJ. Delayed and isolated abducens nerve palsy following minor head injury. Neurol Sci. 2020 Jul;41(7):1951-1953. doi: 10.1007/s10072-020-04260-5. Epub 2020 Jan 25. PMID: 31980970. Ravindran K, Lorensini B, Gaillard F, Kalus S. Bilateral traumatic abducens nerve avulsion: A case series and literature review. J Clin Neurosci. 2017 Oct;44:30-33. doi: 10.1016/j.jocn.2017.06.023. Epub 2017 Jun 30. PMID: 28673673. Tayebi Meybodi A, Borba Moreira L, Little AS, Lawton MT, Preul MC. Anatomical assessment of the endoscopic endonasal approach for the treatment of paraclinoid aneurysms. J Neurosurg. 2018 Dec 21;131(6):1734-1742. doi: 10.3171/2018.6.JNS18800. PMID: 30579271. Fam DJ, Baharnoori M, Kassardjian CD, Saposnik G. Posttraumatic Bilateral Abducens Nerve Palsy: Mechanism of Injury and Prognosis. Can J Neurol Sci. 2015 Sep;42(5):344-6. doi: 10.1017/cjn.2015.57. Epub 2015 Jun 10. PMID: 26062034. Hariharan P, Balzer JR, Anetakis K, Crammond DJ, Thirumala PD. Electrophysiology of Extraocular Cranial Nerves: Oculomotor, Trochlear, and Abducens Nerve. J Clin Neurophysiol. 2018 Jan;35(1):11-15. doi: 10.1097/WNP.0000000000000417. PMID: 29298208. Geressu A, Patil J, Cody J. Acute Abducens Nerve Palsy in a Patient who Sustained Mechanical Trauma to the Orbit. Br Ir Orthopt J. 2021 Dec 9;17(1):150-154. doi: 10.22599/bioj.250. PMID: 34966886; PMCID: PMC8663747. Koshy K, Schnekenburger M, Stark R, Fitzgerald M. Delayed onset sequential bilateral abducens nerve palsies secondary to traumatic CSF leak. Trauma Case Rep. 2022 Jan 4;38:100602. doi: 10.1016/j.tcr.2021.100602. PMID: 35106357; PMCID: PMC8784633. Zhou LY, Su C, Liu TJ, Li XM. Validity and reliability of the Ocular Motor Nerve Palsy Scale. Neural Regen Res. 2018 Oct;13(10):1851-1856. doi: 10.4103/1673-5374.238716. PMID: 30136702; PMCID: PMC6128053. Zhou LY, Li XM, Liu TJ, Ji XJ, Zhao M, Su C, Liu JC, Sun JY. Efficacy of intraorbital electroacupuncture for diabetic abducens nerve palsy: study protocol for a prospective single-center randomized controlled trial. Neural Regen Res. 2017 May;12(5):826-830. doi: 10.4103/1673-5374.206654. PMID: 28616041; PMCID: PMC5461622. Azad TD, Veeravagu A, Corrales CE, Chow KK, Fischbein NJ, Harris OA. Abducens Nerve Avulsion and Facial Nerve Palsy After Temporal Bone Fracture: A Rare Concomitance of Injuries. World Neurosurg. 2016 Apr;88:689.e5-689.e8. doi: 10.1016/j.wneu.2015.11.076. Epub 2015 Dec 23. PMID: 26723286. Asproudis I, Vourda E, Zafeiropoulos P, Katsanos A, Tzoufi M. Isolated abducens nerve palsy after closed head injury in a child. Oman J Ophthalmol. 2015 Sep-Dec;8(3):179-80. doi: 10.4103/0974-620X.169905. PMID: 26903725; PMCID: PMC4738664. Serio F, Choi J, Mccague A. Bilateral Abducens Nerve Palsy after Closed Head Trauma without Acute Intracranial Pathology. J Emerg Trauma Shock. 2019 Jul-Sep;12(3):222-224. doi: 10.4103/JETS.JETS_98_18. PMID: 31543647; PMCID: PMC6735207. Hofer JE, Scavone BM. Cranial nerve VI palsy after dural-arachnoid puncture. Anesth Analg. 2015 Mar;120(3):644-646. doi: 10.1213/ANE.0000000000000587. PMID: 25695579. Bakhsheshian J, Hwang MS, Strickland BA, Khishfe B. Isolated bilateral abducens nerve palsy due to an inflammatory process within the sella and parasellar regions. J Clin Neurosci. 2016 Jan;23:165-168. doi: 10.1016/j.jocn.2015.08.018. Epub 2015 Oct 21. PMID: 26482458. Wysiadecki G, Orkisz S, Gałązkiewicz-Stolarczyk M, Brzeziński P, Polguj M, Topol M. The abducens nerve: its topography and anatomical variations in intracranial course with clinical commentary. Folia Morphol (Warsz). 2015;74(2):236-44. doi: 10.5603/FM.2015.0037. PMID: 26050813. Ding H, Wu X, Wu BW, Xiao LM, Pan LS, Xie SH, Zhan J, Tang B, Hong T. Further investigation of the lateral approach for the resection of Knosp grade 4 pituitary adenomas in endoscopic endonasal surgery. J Neurosurg. 2024 Feb 16:1-11. doi: 10.3171/2023.12.JNS23922. Epub ahead of print. PMID: 38364227. Novotny S, Serrano K, Bazer D, Manganas L. Multiple Cranial Nerve Palsies in a Pediatric Case of Lemierre's Syndrome due to Streptococcus viridans . Case Rep Neurol Med. 2021 Oct 26;2021:4455789. doi: 10.1155/2021/4455789. PMID: 34745672; PMCID: PMC8564190. Tsai CB, Fang CL, Chen MS. Abducens nerve palsy treated by tethering the globe to the lateral orbital rim with a bone screw. J AAPOS. 2021 Apr;25(2):123-125. doi: 10.1016/j.jaapos.2020.11.013. Epub 2021 Feb 27. PMID: 33652103. Revuelta Barbero JM, Subramaniam S, Noiphithak R, Yanez-Siller JC, Otto BA, Carrau RL, Prevedello DM. The Eustachian Tube as a Landmark for Early Identification of the Abducens Nerve During Endonasal Transclival Approaches. Oper Neurosurg (Hagerstown). 2019 Jun 1;16(6):743-749. doi: 10.1093/ons/opy275. PMID: 30257011. Paiva AL, de Aguiar GB, Ferraz VR, Araújo JL, Toita MH, Veiga JC. Retroclival Pneumocephalus Associated with Bilateral Abducens Palsy in a Child. Pediatr Neurosurg. 2016;51(5):269-72. doi: 10.1159/000445905. Epub 2016 May 19. PMID: 27193585. Bansal RK, Bamotra RK. Anterior segment ischemia following Hummelsheim procedure in a case of sixth nerve palsy. Indian J Ophthalmol. 2015 Jun;63(6):543-4. doi: 10.4103/0301-4738.162619. PMID: 26265650; PMCID: PMC4550993. San-juan D, Barges-Coll J, Gómez Amador JL, Díaz MP, Alarcón AV, Escanio E, Anschel DJ, Padilla JA, Barradas VA, Alcantar Aguilar MA, González-Aragón MF. Intraoperative monitoring of the abducens nerve in extended endonasal endoscopic approach: a pilot study technical report. J Electromyogr Kinesiol. 2014 Aug;24(4):558-64. doi: 10.1016/j.jelekin.2014.04.001. Epub 2014 Apr 21. PMID: 24836215. Li G, Zhu X, Gu X, Sun Y, Gao X, Zhang Y, Hou K. Ocular Movement Nerve Palsy After Mild Head Trauma. World Neurosurg. 2016 Oct;94:296-302. doi: 10.1016/j.wneu.2016.06.133. Epub 2016 Jul 12. PMID: 27422684. McDowell MM, Zwagerman NT, Wang EW, Snyderman CH, Tyler-Kabara EC, Gardner PA. Long-term outcomes in the treatment of pediatric skull base chordomas in the endoscopic endonasal era. J Neurosurg Pediatr. 2020 Nov 20;27(2):170-179. doi: 10.3171/2020.6.PEDS19733. PMID: 33254137. Jain C, Mehta A, Bhatia V, Gupta P. Isolated contralateral abducens palsy in direct carotid-cavernous fistula. BMJ Case Rep. 2020 Dec 21;13(12):e238746. doi: 10.1136/bcr-2020-238746. PMID: 33370953; PMCID: PMC7754622. Mata Moret L, Freiria Barreiro R, Cervera Taulet E, Monferrer Adsuara C, Ortiz Salvador M, Palomares Fort P. Nishida procedure associated with botulinum toxin in a long-standing complete bilateral sixth cranial nerve palsy. Arch Soc Esp Oftalmol (Engl Ed). 2019 Oct;94(10):500-503. English, Spanish. doi: 10.1016/j.oftal.2019.05.012. Epub 2019 Jul 17. PMID: 31326157. Salunke P, Madhivanan K, Kamali N, Garg R. Spontaneous recovery of post-traumatic acute bilateral facial and abducens nerve palsy. Asian J Neurosurg. 2016 Oct-Dec;11(4):446. doi: 10.4103/1793-5482.145056. PMID: 27695556; PMCID: PMC4974977. Borg A, Zrinzo L. Aberrant Abducent Nerve During Microvascular Decompression for Trigeminal Neuralgiass. World Neurosurg. 2020 Jun;138:454-456. doi: 10.1016/j.wneu.2020.03.115. Epub 2020 Apr 3. Erratum in: World Neurosurg. 2020 Nov;143:660. PMID: 32251825. Jecko V, Sesay M, Liguoro D. Anatomical location of the abducens nerves (VI) in the ventral approach of clival tumors. Surg Radiol Anat. 2020 Nov;42(11):1371-1375. doi: 10.1007/s00276-020-02525-4. Epub 2020 Jun 30. PMID: 32607642. Moon S, Ko M, Kim S, Kim H, Oh D. Superior cervical sympathetic ganglion block under ultrasound guidance promotes recovery of abducens nerve palsy caused by microvascular ischemia. Scand J Pain. 2019 Dec 18;20(1):211-214. doi: 10.1515/sjpain-2019-0096. PMID: 31541603. Dimou S, Alukaidey L, Nair G. A Case Report of Bilateral Abducens Palsy in the Setting of Clival Fracture - Recovery Related to Pathophysiological Basis of Injury. Neuroophthalmology. 2021 Jan 26;45(5):343-346. doi: 10.1080/01658107.2020.1831549. PMID: 34566216; PMCID: PMC8409766. Han A, Jun W, Winges K. Case Report: Unilateral Cranial Nerve VI Palsy Secondary to Intracranial Hypotension. Optom Vis Sci. 2023 Oct 1;100(10):715-720. doi: 10.1097/OPX.0000000000002063. Epub 2023 Aug 29. PMID: 37639689. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4625149","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":326484358,"identity":"be580d11-9057-43ea-bcf7-4aeef5903dc8","order_by":0,"name":"Xiaofei Hou","email":"","orcid":"","institution":"Xiangya Changde Hospital of Hunan Province","correspondingAuthor":false,"prefix":"","firstName":"Xiaofei","middleName":"","lastName":"Hou","suffix":""},{"id":326484359,"identity":"2c57b01e-4c07-4b1c-a582-aa3d96032e89","order_by":1,"name":"Guancheng Hu","email":"","orcid":"","institution":"Zhangjiajie People's Hospital of Hunan Province","correspondingAuthor":false,"prefix":"","firstName":"Guancheng","middleName":"","lastName":"Hu","suffix":""},{"id":326484360,"identity":"98ad3146-bfba-4eba-bae6-d674a10d0c43","order_by":2,"name":"Hua Fu","email":"","orcid":"","institution":"Zhangjiajie People's Hospital of Hunan Province","correspondingAuthor":false,"prefix":"","firstName":"Hua","middleName":"","lastName":"Fu","suffix":""},{"id":326484361,"identity":"0f7228c0-5e2f-4c1a-908a-43e4e55e6a4b","order_by":3,"name":"ShengWei Yang","email":"data:image/png;base64,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","orcid":"","institution":"Zhangjiajie People's Hospital of Hunan Province","correspondingAuthor":true,"prefix":"","firstName":"ShengWei","middleName":"","lastName":"Yang","suffix":""}],"badges":[],"createdAt":"2024-06-23 12:12:16","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4625149/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4625149/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":65230847,"identity":"684d6562-c3c8-4a8b-8d20-dad17127b0a2","added_by":"auto","created_at":"2024-09-25 04:31:49","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":519739,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4625149/v1/395a6fd2-7b6f-4668-8d6b-0869a886d36f.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Treatment options for traumatic abducens nerve injury: a dual-center clinical experience","fulltext":[{"header":"Introduction","content":"\u003cp\u003eThe abducens nerve, which is the sixth cranial nerve, innervates the lateral rectus muscle of both eyes, controlling the outward movement of the eyeballs\u003csup\u003e[1]\u003c/sup\u003e. Over 10% of abducens nerve palsies result from trauma, with approximately 1\u0026ndash;2.7% of patients with cranial nerve damage following head trauma experiencing involvement of the abducens nerve\u003csup\u003e[2\u0026ndash;3]\u003c/sup\u003e. The abducens nerve enters the orbit via the superior orbital fissure and has a relatively long course along the skull base, making it particularly susceptible to injury during cranial trauma. Additionally, due to its proximity to the internal carotid artery within the cavernous sinus, increased intracranial pressure following head trauma can also affect the abducens nerve\u003csup\u003e[4]\u003c/sup\u003e. Following abducens nerve injury, mild symptoms may include limited outward gaze and diplopia, while severe cases can lead to complete inability to abduct the eye, esotropia, compensatory head posture, dizziness, and unsteady gait, significantly impacting the patient's quality of life\u003csup\u003e[5\u0026ndash;6]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eThere is currently no unified standard for the treatment of the traumatic abductor nerve injury\u003csup\u003e[7]\u003c/sup\u003e. In the early stages, drugs functioned as nourishing nerves, lowering blood pressure, and dilating blood vessels are often chosen for treatment, but the expected therapeutic effects are often not achieved. In some cases, while imaging suggests compression of the abducens nerve by bone fragment, a small surrounding hematoma, or if there is persistent elevation of intracranial pressure, early consideration should be given to performing abducens nerve decompression surgery \u003csup\u003e[8]\u003c/sup\u003e. However, many questions remain unanswered in clinical practice, such as the efficacy of surgery, indications for surgery, and the optimal timing of surgical intervention. Additionally, some emerging treatments, such as stem cell therapy and neurotrophic factor therapy, are showing promising results\u003csup\u003e[9\u0026ndash;10]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eDue to the prolonged self-repair period following abducens nerve injury, neurological dysfunction often persists. For neurosurgeons, having clear and effective treatment strategies for abducens nerve injury and reducing treatment duration is of paramount importance. Based on this, we conducted a retrospective analysis of 71 patients with traumatic abducens nerve injury who underwent treatment at the Department of Neurosurgery in the Zhangjiajie People\u0026rsquo;s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province from January 2021 to December 2023, comparing the efficacy of surgical and conservative treatments, aiming to determine the optimal treatment approach.\u003c/p\u003e"},{"header":"Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eParticipants\u003c/h2\u003e \u003cp\u003eWe collected clinical data from 71 patients diagnosed with traumatic abducens nerve injury who received treatment at the Department of Neurosurgery in both Zhangjiajie People\u0026rsquo;s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province between January 2021 and December 2023. The inclusion criteria were as follows: (1) binocular diplopia; (2) a clear history of head trauma; (3) diagnosed with unilateral abducens nerve palsy; (4) undergone treatment for at least two weeks; (5) clear consciousness and stable vital signs; (6) age over 18 years. Exclusion criteria are as follows: (1) muscle disorders caused by thyroid dysfunction, myasthenia gravis, or other diseases; (2) congenital strabismus; (3) concurrent paralysis of the trochlear nerve or oculomotor nerve; (4) coma or inability to cooperate. For all included cases, we documented the initial ocular position score, gender, age, injured side, cause of injury, treatment plan, treatment duration, and recovery status of eye movement. All methods were conducted in accordance with relevant guidelines and approved by the Ethics Committees of the Zhangjiajie People\u0026rsquo;s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003eDiagnosis\u003c/h2\u003e \u003cp\u003eThe diagnosis of traumatic abducens nerve injury was based on the patient's history of trauma, symptoms, and imaging examination results\u003csup\u003e[11]\u003c/sup\u003e. The diagnosis of the condition is based on the inability of the affected eye to perform outward gaze or limited outward gaze function, with the affected eye deviating towards the nose. Additionally, the patient presents with diplopia and may exhibit compensatory head posture.\u003c/p\u003e \u003cdiv id=\"Sec5\" class=\"Section3\"\u003e \u003ch2\u003eGrouping\u003c/h2\u003e \u003cp\u003eAll 71 patients included in the study met the clinical diagnostic criteria for traumatic abducens nerve injury, with a history of head and facial trauma. Patients who underwent surgical treatment were categorized into the operation group, while those who did not undergo surgical treatment but instead received steroid pulse therapy supplemented with supportive treatment were classified into the conservative treatment group. All patients\u0026rsquo; initial ocular position scores will be recorded and used for subgroup analysis. The ocular position score is determined using the eye movement grading method in the Ocular Motor Nerve Palsy Scale to assess the degree of abduction impairment in patients during their visit\u003csup\u003e[12]\u003c/sup\u003e. A higher score indicates more severe impairment. Complete paralysis is defined as an ocular movement score of 3 or 4 points, where the center point of the pupil does not reach the midpoint between the inner and outer canthi when attempting maximal abduction.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003eManagement\u003c/h2\u003e \u003cp\u003eFor patients in the conservative treatment group, high-dose corticosteroid pulse therapy was typically employed. Initially, within 3\u0026ndash;8 hours post-injury, 500mg of methylprednisolone was administered, followed by a 3-day continuous pulse therapy with the dosage adjusted to 300mg, then further adjusted to 100mg after 3 days. Meanwhile, they were supplemented with diuretics, neurotrophic agents, vasodilators, and hyperbaric oxygen therapy.\u003c/p\u003e \u003cp\u003eFor patients in the operation group, surgical interventions were performed to decompress the abducens nerve. Surgical procedures include both intracranial and extracranial decompression of the abducens nerve, as well as endoscopic trans-nasal decompression. The objective of these surgeries is to alleviate compression on the abducens nerve and facilitate recovery of its function. Following surgery, patients receive antimicrobial therapy, dehydration treatment, vascular nutritional support, and other supportive measures.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003eMeasurements\u003c/h2\u003e \u003cp\u003eBased on reference\u003csup\u003e[13]\u003c/sup\u003e, the efficacy assessment criteria are formulated as follows:\u003c/p\u003e \u003cp\u003eCured: After treatment, the affected eye exhibits unrestricted outward movement, with no strabismus or diplopia when looking straight ahead, and there is no visual field defect.\u003c/p\u003e \u003cp\u003eMarked effective: After treatment, the affected eye exhibits essentially unrestricted outward movement, with no strabismus when looking straight ahead, and the angle of diplopia is less than 30\u0026deg;, and the visual field is basically normal.\u003c/p\u003e \u003cp\u003eEffective: After treatment, there is slight improvement in the outward movement of the affected eye, and there are varying degrees of improvement in the strabismus and diplopia when looking straight ahead, with an increase in the visual field compared to before treatment.\u003c/p\u003e \u003cp\u003eIneffective: After treatment, there is no significant change in the outward movement of the affected eye, and there is no change in diplopia, strabismus, or visual field defect.\u003c/p\u003e \u003cp\u003eThe overall effective rate is calculated as follows: (Number of cured cases\u0026thinsp;+\u0026thinsp;Number of significantly improved cases\u0026thinsp;+\u0026thinsp;Number of effective cases) / Total number of cases \u0026times; 100%.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003eStatistical analysis\u003c/h2\u003e \u003cp\u003eStatistical analysis was conducted using SPSS version 26 (IBM Corp., Armonk, NY, USA). Continuous variables are expressed as mean\u0026thinsp;\u0026plusmn;\u0026thinsp;standard deviation (X\u0026thinsp;\u0026plusmn;\u0026thinsp;S). The t-test was utilized to compare the mean values of continuous variables between two groups. Categorical variables are presented as percentages (%) and were compared between groups using the chi-square test to determine treatment efficacy. A p-value less than 0.05 was considered statistically significant.\u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cdiv id=\"Sec10\" class=\"Section2\"\u003e \u003ch2\u003eBaseline characteristics of patients\u003c/h2\u003e \u003cp\u003eThis study collected a total of 71 cases of traumatic abducens nerve palsy, including 46 males and 25 females. Among them, 38 cases involved the left eye and 33 cases involved the right eye. Imaging examinations such as head CT and MRI suggested intracranial hemorrhage in 31 cases and orbital fractures in 22 cases. Upon initial presentation, the eye position score was 4 points in 19 cases, 3 points in 17 cases, 2 points in 27 cases, 1 point in 8 cases. Complete paralysis was observed in 36 cases while incomplete paralysis in 35 cases. The onset age ranged from 20 to 66 years, with a mean age of 38.95\u0026thinsp;\u0026plusmn;\u0026thinsp;13.09 years in conservative treatment group and 38.15\u0026thinsp;\u0026plusmn;\u0026thinsp;9.82 years in operation group. The results in Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e indicate that there were no statistically significant differences (P\u0026thinsp;\u0026gt;\u0026thinsp;0.05) in gender, age, laterality of eye involvement, or initial ocular position score between two groups, suggesting comparable baseline characteristics between two groups.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eBaseline characteristics of patients\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"6\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePatients\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eSex(male/female)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eAge(x^-\u0026plusmn;s)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eSide\u003c/p\u003e \u003cp\u003e(left/right)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eocular position score\u003c/p\u003e \u003cp\u003e(complete/ incomplete paralysis)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eConservative treatment group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e28/16\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e38.95\u0026thinsp;\u0026plusmn;\u0026thinsp;13.09\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e25/19\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e18/26\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eOperation group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e27\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18/9\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e38.15\u0026thinsp;\u0026plusmn;\u0026thinsp;9.82\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e13/14\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e18/9\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eχ\u003csup\u003e2\u003c/sup\u003e /t\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e-\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e0.067\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.276\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.506\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e3.471\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eP valve\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e-\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e0.795\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.784\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.477\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e0.062\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec11\" class=\"Section2\"\u003e \u003ch2\u003eComparison of therapeutic effects between conservative treatment group and operation group\u003c/h2\u003e \u003cp\u003eThe overall effective rate of conservative treatment group was 81.82%, with 9 patients cured, 15 patients showed marked effective, 12 patients showed effective and 8 patients showed ineffective. The overall effective rate of operation group was 88.89%, with 7 patients cured, 9 patients showed marked effective, 5 patients showed effective and 6 patients showed ineffective. No statistically significant difference (χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;0.173, P\u0026thinsp;=\u0026thinsp;0.678, Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e) between two groups.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComparison of therapeutic effects between conservative treatment group and operation group\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"9\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003ePatients\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eCure(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eMarked effective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eEffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003eIneffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eTotal effective rate(%)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eConservative treatment group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e44\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e9(20.45%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e15(34.09%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e12(27.27%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e8(18.18%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e81.82%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eOperation group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e27\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e7(29.63%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e9(25.93%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e5(33.33%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e6(11.11%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e88.89%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"5\" nameend=\"c9\" namest=\"c5\"\u003e \u003cp\u003eχ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;0.173, P\u0026thinsp;=\u0026thinsp;0.678\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec12\" class=\"Section2\"\u003e \u003ch2\u003eSubgroup analysis: Comparison of ocular position score on therapeutic effects\u003c/h2\u003e \u003cp\u003eAmong the patients received conservative treatment, 18 patients\u0026rsquo; initial ocular position score were no less than 3 and were diagnosed as complete paralysis, with 26 patients\u0026rsquo; initial ocular position score were less than 3 and were diagnosed as incomplete paralysis. The overall effective rate of the incomplete paralysis group was higher than that of the complete paralysis group, with a statistically significant difference (χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;4.70, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05, Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e). Among the patients received operation, 18 patients were diagnosed as complete paralysis and 9 patients were diagnosed as incomplete paralysis. There was still statistically significant difference in the overall effective rate between two groups (χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;3.875, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05, Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComparison of ocular position score on conservative treatment group\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"9\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003ePatients\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eCure(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eMarked effective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eEffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003eIneffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eTotal effective rate(%)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eComplete paralysis group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e3(16.67%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e4(22.22%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e5(27.78%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e6(33.33%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e66.67%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eIncomplete paralysis group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e26\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e6(23.08%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e11(42.31%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e7(26.92%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e2(7.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e92.31%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"5\" nameend=\"c9\" namest=\"c5\"\u003e \u003cp\u003eχ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;4.70, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eComparison of ocular position score on operation group\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"9\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003ePatients\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eCure(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eMarked effective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eEffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c8\"\u003e \u003cp\u003eIneffective(%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c9\"\u003e \u003cp\u003eTotal effective rate(%)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eComplete paralysis group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e18\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e4(22.22%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e5(27.78%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e3(16.67%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e6(33.33%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e66.67%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e \u003cp\u003eIncomplete paralysis group\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e9\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003e3(33.33%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e4(44.44%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e2(22.22%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e0(0%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e100%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"5\" nameend=\"c9\" namest=\"c5\"\u003e \u003cp\u003eχ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;3.857, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003c/div\u003e"},{"header":"Discussion","content":"\u003cp\u003eThe abducens nerve originates from the cerebral cortex, descends to the brainstem nuclei, and then emits secondary neuronal fibers to innervate the lateral rectus muscle of the eye\u003csup\u003e[14\u0026ndash;15]\u003c/sup\u003e. Lesions affecting the horizontal gaze center in the pons, as well as lesions in the cerebral cortex and cortical gaze center, can result in paralysis of the extraocular muscles\u003csup\u003e[16]\u003c/sup\u003e. Due to its relatively long intracranial course, traumatic injury leading to abducens nerve damage is the most common type of peripheral ocular muscle paralysis. After exiting the skull, the abducens nerve traverses the surface of the petrous part of the temporal bone, running between the dura mater and the petrous bone, and then makes a right-angled bend to enter the cavernous sinus\u003csup\u003e[17\u0026ndash;18]\u003c/sup\u003e. This segment of its course is relatively fixed at both ends with little room for movement, making it prone to injury. The abducens nerve must exit the skull through the skull base foramen, which makes it susceptible to injury if the skull base is traumatized and affects the foramen, leading to abducens nerve damage. Skull fractures themselves can cause traction and contusion injuries to intracranial nerves or disrupt the blood supply to cranial nerves due to fracture-related issues, thereby resulting in impairment of the abducens nerve\u003csup\u003e[19\u0026ndash;20]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eAbducens nerve palsy can be classified according to its etiology into ischemic, compressive, traumatic, and non-specific inflammatory types. Ischemic abducens nerve palsy is often associated with conditions such as diabetes mellitus, hypertension, hyperlipidemia, and a history of cerebrovascular accidents\u003csup\u003e[21\u0026ndash;22]\u003c/sup\u003e. Compressive abducens nerve palsy resulting from intracranial space-occupying lesions typically involves lesions near the abducens nerve nucleus or in close proximity to its fibers\u003csup\u003e[23]\u003c/sup\u003e. Traumatic abducens nerve palsy is the most common type encountered by neurosurgeons and is often associated with a clear history of trauma. Among our group of cases, car accidents accounted for 32 cases (45.07%), fights for 20 cases (28.17%), falls for 12 cases (16.90%), and other causes for 7 cases (9.9%).\u003c/p\u003e \u003cp\u003eDamage to the abducens nerve results in weakness of the innervated lateral rectus muscle, leading to exotropia or diplopia, and severe cases may present with compensatory head posture. Unilateral abducens nerve palsy is more common than bilateral cases and presents with either complete or partial paralysis\u003csup\u003e[24]\u003c/sup\u003e. Symptoms include esotropia of the affected eye, restricted or absent outward eye movements, compensatory head tilting toward the affected side, and fixation of the gaze toward the unaffected side. Diplopia is pronounced. In severe cases, walking may require occlusion of one eye\u003csup\u003e[25]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eCurrently, there is still controversy surrounding the treatment approach for traumatic abducens nerve injuries\u003csup\u003e[26\u0026ndash;27]\u003c/sup\u003e. Some physicians advocate for early surgical intervention, especially for patients with bone fragments or small hematomas compressing the abducens nerve, suggesting early decompression surgery. However, other physicians believe that most cases of abducens nerve palsy can recover gradually without surgery, and instead, conservative treatment options such as steroid therapy and neurotrophic drugs can be pursued\u003csup\u003e[28]\u003c/sup\u003e. Steroids have been validated for their significant role in treating nerve injuries.\u003c/p\u003e \u003cp\u003eCorticosteroids, such as prednisone or methylprednisolone, are often used in the management of traumatic abducens nerve injury. In acute nerve injuries, there is often inflammation and swelling around the injured abducens nerve, which can exacerbate tissue damage and impede nerve recovery. Corticosteroids help to reduce this inflammation, potentially minimizing tissue damage and promoting a more favorable environment for nerve regeneration\u003csup\u003e[29]\u003c/sup\u003e. In addition to their anti-inflammatory effects, corticosteroids may also help prevent secondary damage to nerves. After an initial injury, there can be a cascade of biochemical events that lead to further damage to nerve tissue. Corticosteroids may help to interrupt or mitigate this cascade, limiting the extent of secondary damage\u003csup\u003e[30]\u003c/sup\u003e. Corticosteroids are typically administered intravenously in acute nerve injury cases. The dosage and duration of treatment may vary depending on the severity of the injury, individual patient factors, and the neurosurgeon's clinical judgment. A typical regimen might involve an initial high dose followed by a tapering course to gradually reduce the dose over time.\u003c/p\u003e \u003cp\u003eFor patients with evident bone fragments and hematomas compressing the abducens nerve, surgical treatment can be considered. Preoperative assessment through imaging studies and electrophysiology helps identify the site of nerve injury\u003csup\u003e[31]\u003c/sup\u003e. Surgery can be performed via intracranial or extracranial approaches, where bone fragments compressing the nerve are removed using drilling techniques, hematomas around the nerve are evacuated, and the outer membrane of the nerve is incised under a microscope to achieve decompression. Endoscopic trans-nasal decompression surgery for the abducens nerve has also been utilized. Some institutions have started performing microvascular decompression for the abducens nerve\u003csup\u003e[32]\u003c/sup\u003e. Currently, there are no randomized controlled studies evaluating the efficacy of different surgical techniques, so the primary criterion for selection remains the proficiency of the clinical surgeon\u003csup\u003e[33]\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eOur research findings also indicate that there is no significant difference in efficacy between the operation group and the conservative treatment group. The effectiveness rate in the surgical group was 88.89%, while it was 81.82% in the conservative treatment group (χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;0.173, P\u0026thinsp;=\u0026thinsp;0.678). Overall, the prognosis of traumatic abducens nerve injuries remains favorable. Based on our clinical experience, for patients with evident bone fragments and hematomas compressing the abducens nerve, surgical treatment should be preferred to relieve the compressed abducens nerve and salvage its function as early as possible. However, for cases where there is no apparent compression of the abducens nerve, the efficacy of surgery may be less significant. Furthermore, some studies have indicated that the combined effect of nerve decompression surgery and steroid treatment is more beneficial.\u003c/p\u003e \u003cp\u003eBesides, our research has found that patients with higher ocular position scores tend to have more severe symptoms of abducens nerve palsy, and consequently, poorer treatment outcomes. Patients with a ocular deviation score of 3 or above at the time of diagnosis usually have a worse prognosis. This score represents the extent of outward deviation impairment in patients, with higher scores indicating greater ocular misalignment and more severe conditions, leading to poorer treatment outcomes. Subgroup analysis results demonstrate that both in the conservative treatment group and the surgical group, the efficacy rate is significantly lower in the complete paralysis subgroup (ocular deviation score of 3\u0026ndash;4) compared to the incomplete paralysis subgroup (ocular deviation score below 3). Results showed the total effective rate was 92.31% vs .66.67%(χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;4.70, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05) on conservative treatment group and 100% vs .66.67% ༈χ\u003csup\u003e2\u003c/sup\u003e\u0026thinsp;=\u0026thinsp;3.857, P\u0026thinsp;\u0026lt;\u0026thinsp;0.05༉on operation group. This may be due to an increase in energy production by surviving neurons, with a reduction in acidic metabolic by-products, which in turn self-corrects the imbalance of ions both inside and outside the cells. This process accelerates the regeneration of capillaries and the establishment of collateral circulation, providing damaged nerve tissue with ample nutritional substances, thereby promoting the repair of its own nerve fibers and myelin sheaths. Furthermore, compared to complete paralysis, incomplete paralysis of the abducens nerve still partially innervates the lateral rectus muscle and retains some degree of activity. This helps prevent tissue atrophy and facilitates early restoration of its activity, thereby promoting nerve function recovery.\u003c/p\u003e \u003cp\u003eIn addition, for patients with strabismus symptoms that are refractory to conservative treatment or decompression surgery, consideration could be given to referring the patient to ophthalmology for corrective surgery after 6\u0026ndash;8 months\u003csup\u003e[34\u0026ndash;35]\u003c/sup\u003e. The aim is to achieve visual recovery and promote normal ocular alignment. Traditional corrective surgeries in clinical practice have gradually been phased out with the development of scientific technology due to risks such as anatomical layer disruption and misalignment of incisions, leading to poor treatment outcomes and a higher likelihood of postoperative complications. However, in recent years, the emergence of minimally invasive surgeries has addressed the shortcomings of traditional surgeries\u003csup\u003e[36]\u003c/sup\u003e. Commonly used procedures include Jensen's procedure, Hummelsheim's procedure, and Brooks' procedure. Microscopic medial rectus transposition surgery is a safe and effective procedure for treating patients with exotropic strabismus caused by complete paralysis of the abducens nerve.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThe total effectiveness rate of the conservative treatment group was similar to that of the operation group, suggesting no difference in treatment effectiveness between two treatment plans, and the prognosis of traumatic abducens nerve injuries remains favorable. However, the higher the initial ocular position score of the patient, the more severe the paralysis symptoms, and the worse the treatment effect. Thus, treatment choices should be individualized to ensure optimal results.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe are grateful to the participating patients.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor disclosure statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNo conflict of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets used and analysed during the current study available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthical Approval\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe study was approved by the Ethics Committees of the Zhangjiajie People\u0026rsquo;s Hospital of Hunan Province and Xiangya Changde Hospital of Hunan Province. Informed written consent for study participation was obtained from all patients.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNo competing financial interests exist.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eAlkhatib RF, Chen RC, Sing BWH, Sanamandra SK. Unilateral abducens nerve avulsion injury following trauma. Singapore Med J. 2023 Nov 9. doi: 10.4103/singaporemedj.SMJ-2022-222. Epub ahead of print. PMID: 38037779.\u003c/li\u003e\n\u003cli\u003eFawaz R, Hedjoudje M, Law-Ye B. Abducens nerve avulsion sustained by traumatic brain injury: A lesion not to be underestimated. J Neurosci Rural Pract. 2023 Oct-Dec;14(4):591-592. doi: 10.25259/JNRP_226_2023. Epub 2023 Jul 5. PMID: 38059240; PMCID: PMC10696310.\u003c/li\u003e\n\u003cli\u003eHeo H, Lambert SR. Ocular Motor Nerve Palsy After Traumatic Brain Injury: A Claims Database Study. J Neuroophthalmol. 2023 Mar 1;43(1):131-136. doi: 10.1097/WNO.0000000000001635. Epub 2022 Jun 14. PMID: 36166785; PMCID: PMC10635738.\u003c/li\u003e\n\u003cli\u003eSharma A, Nguyen HS, Sharma A, Lozen A, Kurpad S. Delayed hydrocephalus associated with traumatic atlanto-occipital dislocation: Case report and literature review. Surg Neurol Int. 2016 Sep 22;7(Suppl 25):S679-S681. doi: 10.4103/2152-7806.191076. PMID: 27843685; PMCID: PMC5054641.\u003c/li\u003e\n\u003cli\u003eLee JY, Yoo YJ. Delayed and isolated abducens nerve palsy following minor head injury. Neurol Sci. 2020 Jul;41(7):1951-1953. doi: 10.1007/s10072-020-04260-5. Epub 2020 Jan 25. PMID: 31980970.\u003c/li\u003e\n\u003cli\u003eRavindran K, Lorensini B, Gaillard F, Kalus S. Bilateral traumatic abducens nerve avulsion: A case series and literature review. J Clin Neurosci. 2017 Oct;44:30-33. doi: 10.1016/j.jocn.2017.06.023. Epub 2017 Jun 30. PMID: 28673673.\u003c/li\u003e\n\u003cli\u003eTayebi Meybodi A, Borba Moreira L, Little AS, Lawton MT, Preul MC. Anatomical assessment of the endoscopic endonasal approach for the treatment of paraclinoid aneurysms. J Neurosurg. 2018 Dec 21;131(6):1734-1742. doi: 10.3171/2018.6.JNS18800. PMID: 30579271.\u003c/li\u003e\n\u003cli\u003eFam DJ, Baharnoori M, Kassardjian CD, Saposnik G. Posttraumatic Bilateral Abducens Nerve Palsy: Mechanism of Injury and Prognosis. Can J Neurol Sci. 2015 Sep;42(5):344-6. doi: 10.1017/cjn.2015.57. Epub 2015 Jun 10. PMID: 26062034.\u003c/li\u003e\n\u003cli\u003eHariharan P, Balzer JR, Anetakis K, Crammond DJ, Thirumala PD. Electrophysiology of Extraocular Cranial Nerves: Oculomotor, Trochlear, and Abducens Nerve. J Clin Neurophysiol. 2018 Jan;35(1):11-15. doi: 10.1097/WNP.0000000000000417. PMID: 29298208.\u003c/li\u003e\n\u003cli\u003eGeressu A, Patil J, Cody J. Acute Abducens Nerve Palsy in a Patient who Sustained Mechanical Trauma to the Orbit. Br Ir Orthopt J. 2021 Dec 9;17(1):150-154. doi: 10.22599/bioj.250. PMID: 34966886; PMCID: PMC8663747.\u003c/li\u003e\n\u003cli\u003eKoshy K, Schnekenburger M, Stark R, Fitzgerald M. Delayed onset sequential bilateral abducens nerve palsies secondary to traumatic CSF leak. Trauma Case Rep. 2022 Jan 4;38:100602. doi: 10.1016/j.tcr.2021.100602. PMID: 35106357; PMCID: PMC8784633.\u003c/li\u003e\n\u003cli\u003eZhou LY, Su C, Liu TJ, Li XM. Validity and reliability of the Ocular Motor Nerve Palsy Scale. Neural Regen Res. 2018 Oct;13(10):1851-1856. doi: 10.4103/1673-5374.238716. PMID: 30136702; PMCID: PMC6128053.\u003c/li\u003e\n\u003cli\u003eZhou LY, Li XM, Liu TJ, Ji XJ, Zhao M, Su C, Liu JC, Sun JY. Efficacy of intraorbital electroacupuncture for diabetic abducens nerve palsy: study protocol for a prospective single-center randomized controlled trial. Neural Regen Res. 2017 May;12(5):826-830. doi: 10.4103/1673-5374.206654. PMID: 28616041; PMCID: PMC5461622.\u003c/li\u003e\n\u003cli\u003eAzad TD, Veeravagu A, Corrales CE, Chow KK, Fischbein NJ, Harris OA. Abducens Nerve Avulsion and Facial Nerve Palsy After Temporal Bone Fracture: A Rare Concomitance of Injuries. World Neurosurg. 2016 Apr;88:689.e5-689.e8. doi: 10.1016/j.wneu.2015.11.076. Epub 2015 Dec 23. PMID: 26723286.\u003c/li\u003e\n\u003cli\u003eAsproudis I, Vourda E, Zafeiropoulos P, Katsanos A, Tzoufi M. Isolated abducens nerve palsy after closed head injury in a child. Oman J Ophthalmol. 2015 Sep-Dec;8(3):179-80. doi: 10.4103/0974-620X.169905. PMID: 26903725; PMCID: PMC4738664.\u003c/li\u003e\n\u003cli\u003eSerio F, Choi J, Mccague A. Bilateral Abducens Nerve Palsy after Closed Head Trauma without Acute Intracranial Pathology. J Emerg Trauma Shock. 2019 Jul-Sep;12(3):222-224. doi: 10.4103/JETS.JETS_98_18. PMID: 31543647; PMCID: PMC6735207.\u003c/li\u003e\n\u003cli\u003eHofer JE, Scavone BM. Cranial nerve VI palsy after dural-arachnoid puncture. Anesth Analg. 2015 Mar;120(3):644-646. doi: 10.1213/ANE.0000000000000587. PMID: 25695579.\u003c/li\u003e\n\u003cli\u003eBakhsheshian J, Hwang MS, Strickland BA, Khishfe B. Isolated bilateral abducens nerve palsy due to an inflammatory process within the sella and parasellar regions. J Clin Neurosci. 2016 Jan;23:165-168. doi: 10.1016/j.jocn.2015.08.018. Epub 2015 Oct 21. PMID: 26482458.\u003c/li\u003e\n\u003cli\u003eWysiadecki G, Orkisz S, Gałązkiewicz-Stolarczyk M, Brzeziński P, Polguj M, Topol M. The abducens nerve: its topography and anatomical variations in intracranial course with clinical commentary. Folia Morphol (Warsz). 2015;74(2):236-44. doi: 10.5603/FM.2015.0037. PMID: 26050813.\u003c/li\u003e\n\u003cli\u003eDing H, Wu X, Wu BW, Xiao LM, Pan LS, Xie SH, Zhan J, Tang B, Hong T. Further investigation of the lateral approach for the resection of Knosp grade 4 pituitary adenomas in endoscopic endonasal surgery. J Neurosurg. 2024 Feb 16:1-11. doi: 10.3171/2023.12.JNS23922. Epub ahead of print. PMID: 38364227.\u003c/li\u003e\n\u003cli\u003eNovotny S, Serrano K, Bazer D, Manganas L. Multiple Cranial Nerve Palsies in a Pediatric Case of Lemierre\u0026apos;s Syndrome due to \u003cem\u003eStreptococcus viridans\u003c/em\u003e. Case Rep Neurol Med. 2021 Oct 26;2021:4455789. doi: 10.1155/2021/4455789. PMID: 34745672; PMCID: PMC8564190.\u003c/li\u003e\n\u003cli\u003eTsai CB, Fang CL, Chen MS. Abducens nerve palsy treated by tethering the globe to the lateral orbital rim with a bone screw. J AAPOS. 2021 Apr;25(2):123-125. doi: 10.1016/j.jaapos.2020.11.013. Epub 2021 Feb 27. PMID: 33652103.\u003c/li\u003e\n\u003cli\u003eRevuelta Barbero JM, Subramaniam S, Noiphithak R, Yanez-Siller JC, Otto BA, Carrau RL, Prevedello DM. The Eustachian Tube as a Landmark for Early Identification of the Abducens Nerve During Endonasal Transclival Approaches. Oper Neurosurg (Hagerstown). 2019 Jun 1;16(6):743-749. doi: 10.1093/ons/opy275. PMID: 30257011.\u003c/li\u003e\n\u003cli\u003ePaiva AL, de Aguiar GB, Ferraz VR, Ara\u0026uacute;jo JL, Toita MH, Veiga JC. Retroclival Pneumocephalus Associated with Bilateral Abducens Palsy in a Child. Pediatr Neurosurg. 2016;51(5):269-72. doi: 10.1159/000445905. Epub 2016 May 19. PMID: 27193585.\u003c/li\u003e\n\u003cli\u003eBansal RK, Bamotra RK. Anterior segment ischemia following Hummelsheim procedure in a case of sixth nerve palsy. Indian J Ophthalmol. 2015 Jun;63(6):543-4. doi: 10.4103/0301-4738.162619. PMID: 26265650; PMCID: PMC4550993.\u003c/li\u003e\n\u003cli\u003eSan-juan D, Barges-Coll J, G\u0026oacute;mez Amador JL, D\u0026iacute;az MP, Alarc\u0026oacute;n AV, Escanio E, Anschel DJ, Padilla JA, Barradas VA, Alcantar Aguilar MA, Gonz\u0026aacute;lez-Arag\u0026oacute;n MF. Intraoperative monitoring of the abducens nerve in extended endonasal endoscopic approach: a pilot study technical report. J Electromyogr Kinesiol. 2014 Aug;24(4):558-64. doi: 10.1016/j.jelekin.2014.04.001. Epub 2014 Apr 21. PMID: 24836215.\u003c/li\u003e\n\u003cli\u003eLi G, Zhu X, Gu X, Sun Y, Gao X, Zhang Y, Hou K. Ocular Movement Nerve Palsy After Mild Head Trauma. World Neurosurg. 2016 Oct;94:296-302. doi: 10.1016/j.wneu.2016.06.133. Epub 2016 Jul 12. PMID: 27422684.\u003c/li\u003e\n\u003cli\u003eMcDowell MM, Zwagerman NT, Wang EW, Snyderman CH, Tyler-Kabara EC, Gardner PA. Long-term outcomes in the treatment of pediatric skull base chordomas in the endoscopic endonasal era. J Neurosurg Pediatr. 2020 Nov 20;27(2):170-179. doi: 10.3171/2020.6.PEDS19733. PMID: 33254137.\u003c/li\u003e\n\u003cli\u003eJain C, Mehta A, Bhatia V, Gupta P. Isolated contralateral abducens palsy in direct carotid-cavernous fistula. BMJ Case Rep. 2020 Dec 21;13(12):e238746. doi: 10.1136/bcr-2020-238746. PMID: 33370953; PMCID: PMC7754622.\u003c/li\u003e\n\u003cli\u003eMata Moret L, Freiria Barreiro R, Cervera Taulet E, Monferrer Adsuara C, Ortiz Salvador M, Palomares Fort P. Nishida procedure associated with botulinum toxin in a long-standing complete bilateral sixth cranial nerve palsy. Arch Soc Esp Oftalmol (Engl Ed). 2019 Oct;94(10):500-503. English, Spanish. doi: 10.1016/j.oftal.2019.05.012. Epub 2019 Jul 17. PMID: 31326157.\u003c/li\u003e\n\u003cli\u003eSalunke P, Madhivanan K, Kamali N, Garg R. Spontaneous recovery of post-traumatic acute bilateral facial and abducens nerve palsy. Asian J Neurosurg. 2016 Oct-Dec;11(4):446. doi: 10.4103/1793-5482.145056. PMID: 27695556; PMCID: PMC4974977.\u003c/li\u003e\n\u003cli\u003eBorg A, Zrinzo L. Aberrant Abducent Nerve During Microvascular Decompression for Trigeminal Neuralgiass. World Neurosurg. 2020 Jun;138:454-456. doi: 10.1016/j.wneu.2020.03.115. Epub 2020 Apr 3. Erratum in: World Neurosurg. 2020 Nov;143:660. PMID: 32251825.\u003c/li\u003e\n\u003cli\u003eJecko V, Sesay M, Liguoro D. Anatomical location of the abducens nerves (VI) in the ventral approach of clival tumors. Surg Radiol Anat. 2020 Nov;42(11):1371-1375. doi: 10.1007/s00276-020-02525-4. Epub 2020 Jun 30. PMID: 32607642.\u003c/li\u003e\n\u003cli\u003eMoon S, Ko M, Kim S, Kim H, Oh D. Superior cervical sympathetic ganglion block under ultrasound guidance promotes recovery of abducens nerve palsy caused by microvascular ischemia. Scand J Pain. 2019 Dec 18;20(1):211-214. doi: 10.1515/sjpain-2019-0096. PMID: 31541603.\u003c/li\u003e\n\u003cli\u003eDimou S, Alukaidey L, Nair G. A Case Report of Bilateral Abducens Palsy in the Setting of Clival Fracture - Recovery Related to Pathophysiological Basis of Injury. Neuroophthalmology. 2021 Jan 26;45(5):343-346. doi: 10.1080/01658107.2020.1831549. PMID: 34566216; PMCID: PMC8409766.\u003c/li\u003e\n\u003cli\u003eHan A, Jun W, Winges K. Case Report: Unilateral Cranial Nerve VI Palsy Secondary to Intracranial Hypotension. Optom Vis Sci. 2023 Oct 1;100(10):715-720. doi: 10.1097/OPX.0000000000002063. Epub 2023 Aug 29. PMID: 37639689.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"traumatic abducens nerve injury, ocular position score, surgery, corticosteroid pulse therapy","lastPublishedDoi":"10.21203/rs.3.rs-4625149/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4625149/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eObjective: \u003c/strong\u003eThis study aimed to assess the therapeutic efficacy of surgical and conservative treatments in patients with traumatic abducens nerve injury on neurofunctional recovery based on dual-center clinical experience.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods: \u003c/strong\u003eA retrospective analysis was conducted on the clinical data of 71 patients with traumatic abducens nerve injury. Patients were categorized into the operation group and the conservative treatment group based on whether patients underwent surgical intervention during their hospitalization. A comparison was made between the two groups regarding ocular motility recovery before and after treatment. In addition, patients were further divided into complete paralysis and incomplete paralysis groups based on their initial ocular position score for subgroup analysis.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults: \u003c/strong\u003eThe overall effective rate of conservative treatment group was 81.82%, while the overall effective rate of operation group was 88.89%. there is no statistically significant difference (χ\u003csup\u003e2\u003c/sup\u003e=0.173, P=0.678) between two groups. Subgroup analysis indicated that both in the conservative treatment group and in the surgical group, the efficacy rate is significantly lower in the complete paralysis subgroup compared to the incomplete paralysis subgroup. Results showed the total effective rate was 92.31% vs .66.67%(χ\u003csup\u003e2\u003c/sup\u003e=4.70, P\u0026lt;0.05) on conservative treatment group and 100% vs .66.67% (χ\u003csup\u003e2\u003c/sup\u003e=3.857, P\u0026lt;0.05)on operation group.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion: \u003c/strong\u003eThe total effectiveness rate of the conservative treatment group was similar to that of the operation group, suggesting no difference in treatment effectiveness between two treatment plans, and the prognosis of traumatic abducens nerve injuries remains favorable. However, the higher the initial ocular position score of the patient, the more severe the paralysis symptoms, and the worse the treatment effect. Thus, treatment choices should be individualized to ensure optimal results.\u003c/p\u003e","manuscriptTitle":"Treatment options for traumatic abducens nerve injury: a dual-center clinical experience","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-07-18 05:32:04","doi":"10.21203/rs.3.rs-4625149/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"976c99b8-57dd-4162-92ff-be8c06ad335b","owner":[],"postedDate":"July 18th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":34547982,"name":"Health sciences/Diseases/Trauma"},{"id":34547983,"name":"Health sciences/Neurology/Neurological disorders/Brain injuries"}],"tags":[],"updatedAt":"2024-09-25T04:23:41+00:00","versionOfRecord":[],"versionCreatedAt":"2024-07-18 05:32:04","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4625149","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4625149","identity":"rs-4625149","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.